InfuSystem Holdings Inc. has announced its second quarter 2025 financial results, reporting record net revenues of $36.0 million, representing a 7% growth from the prior year. The company experienced a significant increase in net income, which rose to $2.6 million, a 262% increase compared to the previous year. Earnings per share were reported at $0.12 per diluted share, up from $0.03 per diluted share in the prior year. The company's adjusted EBITDA (non-GAAP) was $8.0 million, reflecting a 32% increase from the previous year, with the adjusted EBITDA margin expanding by 4.3% to 22.3%. Gross profit also saw a notable increase of 19%, amounting to $19.9 million, with a gross margin of 55.2%, an increase of 5.7% from the prior year. InfuSystem's net operating cash flow grew by 227% to $8.8 million. The company also reported stock repurchases totaling $3.5 million during the quarter, with total liquidity reaching $49.1 million as of June 30, 2025. In terms of guidance for the full year 2025, InfuSystem updated its net revenue growth estimate to be in the range of 6% to 8%, a revision from the prior range of 8% to 10%. The company also forecasts an adjusted EBITDA margin of 20% or higher, representing a 120 basis point increase over 2024.